Retrospective analysis of institutional outcomes with FOLFIRINOX versus nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer

被引：0
|
作者：
Singh, Amisha
Shroff, Rachna T.
McBride, Ali
机构：
[1] Univ Arizona, Coll Med, Tucson, AZ USA
[2] Univ Arizona, Canc Ctr, Tucson, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
776
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Modified FOLFIRINOX for metastatic pancreatic adenocarcinoma after failure of nab-paclitaxel plus gemcitabine.
    Ozaka, Masato
    Sasaki, Takashi
    Kataoka, Seita
    Kanata, Ryo
    Ishigaki, Kazunaga
    Yamada, Ikuhiro
    Matsuyama, Masato
    Takano, Koichi
    Sasahira, Naoki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [32] Gemcitabine plus nab-paclitaxel vs. FOLFIRINOX for patients with advanced pancreatic cancer
    Tahara, Junko
    Shimizu, Kyoko
    Otsuka, Nao
    Akao, Junichi
    Takayama, Yukiko
    Tokushige, Katsutoshi
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (02) : 245 - 250
  • [33] Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States
    Sunnie Kim
    James E. Signorovitch
    Hongbo Yang
    Oscar Patterson-Lomba
    Cheryl Q. Xiang
    Brian Ung
    Monika Parisi
    John L. Marshall
    [J]. Advances in Therapy, 2018, 35 : 1564 - 1577
  • [34] Comparative effectiveness of gemcitabine vs gemcitabine plus nab-paclitaxel vs FOLFIRINOX for unresectable pancreatic cancer
    Yamamoto, Shun
    Ueno, Hideki
    Tanaka, Midori
    Inagaki, Yuji
    Ohba, Akihiro
    Sakamoto, Yasunari
    Kondo, Shunsuke
    Morizane, Chigusa
    Okusaka, Takuji
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [35] Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States
    Kim, Sunnie
    Signorovitch, James E.
    Yang, Hongbo
    Patterson-Lomba, Oscar
    Xiang, Cheryl Q.
    Ung, Brian
    Parisi, Monika
    Marshall, John L.
    [J]. ADVANCES IN THERAPY, 2018, 35 (10) : 1564 - 1577
  • [36] Survival outcomes based on sequence of therapy using FOLFIRINOX and nab-paclitaxel plus gemcitabine in metastatic pancreatic ductal adenocarcinoma
    Baron, Kelsey
    Nevala-Plagemann, Christopher Duane
    Moser, Justin
    Haaland, Benjamin
    Wang, Xuechen
    Garrido-Laguna, Ignacio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [37] Comparative effectiveness of FOLFIRINOX or nab-paclitaxel plus gemcitabine in locally advanced or metastatic pancreatic cancer: A population-based analysis
    Wang, Ying
    Chen, Leo
    Camateros, Pierre
    Gill, Sharlene
    Renouf, Daniel John
    Cheung, Winson Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [38] Survival Outcomes Based on Sequence of Therapy Using FOLFIRINOX and Nab-Paclitaxel plus Gemcitabine in Metastatic Pancreatic Ductal Adenocarcinoma
    Baron, Margaret Kelsey
    Wang, Xuechen
    Nevala-Plagemann, Christopher
    Moser, Justin C.
    Haaland, Benjamin
    Garrido-Laguna, Ignacio
    [J]. PANCREAS, 2021, 50 (06) : 796 - 802
  • [39] Comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in metastatic pancreatic cancer: A nationwide chart review in the United States.
    Kim, Sunnie S.
    Signorovitch, James
    Yang, Hongbo
    Patterson-Lomba, Oscar
    Xiang, Cheryl
    Ung, Brian
    Parisi, Monika
    Marshall, John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [40] ECONOMIC EVALUATION OF NAB-PACLITAXEL PLUS GEMCITABINE VERSUS GEMCITABINE ALONE FOR THE MANAGEMENT OF METASTATIC PANCREATIC CANCER IN GREECE
    Fragoulakis, V
    Papakostas, P.
    Pentheroudakis, G.
    Dervenis, C.
    Maniadakis, N.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A632 - A632
12345